The role of E. coli infection in the pathogenesis of primary biliary cirrhosis

Disease Markers

Volumn 29, Issue 6, 2010, Pages 301-311

  Bogdanos, Dimitrios P ^b   Baum, Harold ^b   Vergani, Diego ^b   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoimmune disease; Autoimmunity; Bile ducts; Cholestasis; Cross reactivity; Immunity; Liver; Mimicry; Tolerance

Indexed keywords

2 OXOACID DEHYDROGENASE; 2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; CROSS REACTION; DISEASE ASSOCIATION; DISEASE COURSE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOREACTIVITY; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; T LYMPHOCYTE; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 79951629112     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0745     Document Type: Review

References (90)

1. M.M. Kaplan and M.E. Gershwin, Primary biliary cirrhosis, N Engl J Med 353 (2005), 1261-1273. (Pubitemid 41345948)
2. C. Selmi, F. Meda, A. Kasangian, P. Invernizzi, Z. Tian, Z. Lian, M. Podda and M.E. Gershwin, Experimental evidence on the immunopathogenesis of primary biliary cirrhosis, Cell Mol Immunol 7, 1-10.
3. M.E.Gershwin and I.R.Mackay, The causes of primary biliary cirrhosis: Convenient and inconvenient truths, Hepatology 47 (2008), 737-745. (Pubitemid 351280742)
4. D. Vergani, D.P. Bogdanos and H. Baum, Unusual suspects in primary biliary cirrhosis, Hepatology 39 (2004), 38-41. (Pubitemid 38461464)
5. D.P. Bogdanos and D. Vergani, Origin of crossreactive autoimmunity in primary biliary cirrhosis, Liver Int 26 (2006), 633-635. (Pubitemid 43983878)
6. D.E. Jones, Pathogenesis of primary biliary cirrhosis, Gut 56 (2007), 1615-1624.
7. D.P. Bogdanos and D. Vergani, Bacteria and primary biliary cirrhosis, Clin Rev Allergy Immunol 36 (2009), 30-39.
8. D.P. Bogdanos, K. Choudhuri and D. Vergani, Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences, Liver 21 (2001), 225-232. (Pubitemid 32677377)
9. J. Neuberger, Primary biliary cirrhosis, Lancet 350 (1997), 875-879. (Pubitemid 27404357)
10. S. Hohenester, R.P. OudeElferink and U. Beuers, Primary biliary cirrhosis, Semin Immunopathol 31 (2009), 283-307.
11. I.R. Mackay, S. Whittingham, S. Fida, M. Myers, N. Ikuno, M.E. Gershwin and M.J. Rowley, The peculiar autoimmunity of primary biliary cirrhosis, Immunol Rev 174 (2000), 226-237. (Pubitemid 30201391)
12. J.Van deWater, H. Ishibashi, R.L. Coppel andM.E.Gershwin, Molecular mimicry and primary biliary cirrhosis: premises not promises, Hepatology 33 (2001), 771-775. (Pubitemid 32246623)
13. C. Selmi, D.L. Balkwill, P. Invernizzi, A.A. Ansari, R.L. Coppel, M. Podda, P.S. Leung, T.P. Kenny, J. Van De Water, M.H. Nantz, M.J. Kurth and M.E. Gershwin, Patients with primary biliary cirrhosis react against a ubiquitous xenobioticmetabolizing bacterium, Hepatology 38 (2003), 1250-1257. (Pubitemid 37314834)
14. L. Xu, Z. Shen, L. Guo, B. Fodera, A. Keogh, R. Joplin, B. O-Donnell, J. Aitken, W. Carman, J. Neuberger and A. Mason, Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 100 (2003), 8454-8459. (Pubitemid 36842566)
15. D. Bogdanos, T. Pusl, C. Rust, D. Vergani and U. Beuers, Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis, J Hepatol (2008).
16. D.P. Bogdanos, H. Baum, F. Gunsar, D. Arioli, D. Polymeros, Y. Ma, A.K. Burroughs and D. Vergani, Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological crossreactivity, Scand J Gastroenterol 39 (2004), 981-987. (Pubitemid 39388463)
17. D.P. Bogdanos, H. Baum, A. Grasso, M. Okamoto, P. Butler, Y. Ma, E. Rigopoulou, P. Montalto, E.T. Davies, A.K. Burroughs and D. Vergani, Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis, J Hepatol 40 (2004), 31-39. (Pubitemid 38064710)
18. D.P. Bogdanos, H. Baum, M. Okamoto, P. Montalto, U.C. Sharma, E.I. Rigopoulou, J. Vlachogiannakos, Y. Ma, A.K. Burroughs and D. Vergani, Primary biliary cirrhosis is characterized by IgG3 antibodies crossreactive with the major mitochondrial autoepitope and its Lactobacillus mimic, Hepatology 42 (2005), 458-465. (Pubitemid 41061099)
19. D.P. Bogdanos, H. Baum, U.C. Sharma, A. Grasso, Y. Ma, A.K. Burroughs and D. Vergani, Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis,J Hepatol 36 (2002), 14-21. (Pubitemid 34234011)
20. I. Mayo, P. Arizti, A. Pares, J. Oliva, R.A. Doforno, M.R. de Sagarra, J. Rodes and J.G. Castano, Antibodies against the COOHterminal region of E. coli ClpP protease in patients with primary biliary cirrhosis, J Hepatol 33 (2000), 528-536.
21. S. Shimoda, M. Nakamura, H. Shigematsu, H. Tanimoto, T. Gushima, M.E. Gershwin and H. Ishibashi, Mimicry peptides of human PDCE2 163-176 peptide, the immunodominant Tcell epitope of primary biliary cirrhosis, Hepatology 31 (2000), 1212-1216. (Pubitemid 30351280)
22. D. TaylorRobinson, A.W. Sharif, N.S. Dhanjal and S.D. TaylorRobinson, Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis, J Hepatol 42 (2005), 779-780.
23. L. Vilagut, A. Pares, O. Vinas, J. Vila, M.T. Jimenez de Anta and J. Rodes, Antibodies to mycobacterial 65kD heat shock protein crossreact with the main mitochondrial antigens in patients with primary biliary cirrhosis, Eur J Clin Invest 27 (1997), 667-672. (Pubitemid 27368297)
24. C. Selmi, S.R. Ross, A.A. Ansari, P. Invernizzi, M. Podda, R.L. Coppel and M.E. Gershwin, Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis, Gastroenterology 127 (2004), 493-501. (Pubitemid 39091898)
25. A.S. Abdulkarim, L.M. Petrovic, W.R. Kim, P. Angulo, R.V. Lloyd andK.D. Lindor, Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol 40 (2004), 380-384. (Pubitemid 38230836)
26. D.P. Bogdanos, A. Koutsoumpas, H. Baum and D. Vergani, Borrelia Burgdorferi: a new selfmimicking trigger in primary biliary cirrhosis, Dig Liver Dis 38 (2006), 781-782; author reply 782-783. (Pubitemid 44356278)
27. D.P. Bogdanos, A. Pares, H. Baum, L. Caballeria, E.I. Rigopoulou, Y.Ma, A.K. Burroughs, J. Rodes and D. Vergani, Diseasespecific crossreactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis, J Autoimmun 22 (2004), 353-362. (Pubitemid 38543228)
28. A. Koutsoumpas, M. Mytilinaiou, D. Polymeros, G.N. Dalekos and D.P. Bogdanos, AntiHelicobacter pylori antibody responses specific forVacAdo not trigger primary biliary cirrhosisspecific antimitochondrial antibodies, Eur J Gastroenterol Hepatol 21 (2009), 1220.
29. A.K. Burroughs, I.J. Rosenstein, O. Epstein, J.M. HamiltonMiller, W. Brumfitt and S. Sherlock, Bacteriuria and primary biliary cirrhosis, Gut 25 (1984), 133-137. (Pubitemid 14131405)
30. A.K. Burroughs, P. Butler, M.J. Sternberg and H. Baum, Molecular mimicry in liver disease, Nature 358 (1992), 377-378.
31. P. Butler, J. HamiltonMiller, H. Baum and A.K. Burroughs, Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int 35 (1995), 473-485. (Pubitemid 26177820)
32. D.P. Bogdanos, H. Baum, P. Butler, E.I. Rigopoulou, E.T. Davies, Y. Ma, A.K. Burroughs and D. Vergani, Association between the primary biliary cirrhosis specific antisp100 antibodies and recurrent urinary tract infection, Dig Liver Dis 35 (2003), 801-805. (Pubitemid 41070511)
33. D.P. Bogdanos, H. Baum and D. Vergani, Antimitochondrial and other autoantibodies, Clin Liver Dis 7 (2003), 759-777, vi. (Pubitemid 37229503)
34. D.P.Bogdanos, C. Liaskos, E.I.Rigopoulou andG.N.Dalekos, Antimitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen, Clin Chim Acta 373 (2006), 183-184; author reply 185. (Pubitemid 44308539)
35. W. Bernal, F. Meda, Y. Ma, D.P. Bogdanos and D. Vergani, Diseasespecific autoantibodies in patients with acute liver failure: the King-s College London experience, Hepatology 47 (2008), 1096-1097. (Pubitemid 351449704)
36. D.P. Bogdanos, P. Invernizzi, I.R. Mackay and D. Vergani, Autoimmune liver serology: current diagnostic and clinical challenges, World J Gastroenterol 14 (2008), 3374-3387.
37. D. Vergani and D.P. Bogdanos, Positive markers in AMAnegative PBC, Am J Gastroenterol 98 (2003), 241-243.
38. S. Moteki, P.S. Leung, R.L. Coppel, E.R. Dickson, M.M. Kaplan, S.Munoz andM.E.Gershwin, Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies, Hepatology 24 (1996), 97-103. (Pubitemid 26249419)
39. C. Liaskos, D.P.Bogdanos, E.I.Rigopoulou andG.N.Dalekos, Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?, J Gastroenterol Hepatol 22 (2007), 454-455. (Pubitemid 46238785)
40. M.G. Mytilinaiou and D.P. Bogdanos, Primary biliary cirrhosisspecific autoantibodies in patients with systemic sclerosis, Dig Liver Dis 41 (2009), 916; author reply 916-917.
41. C. Dahnrich, A. Pares, L. Caballeria, A. Rosemann, W. Schlumberger, C. Probst, M. Mytilinaiou, D. Bogdanos, D. Vergani, W. Stocker and L. Komorowski, New ELISA for detecting primary biliary cirrhosisspecific antimitochondrial antibodies, Clin Chem 55 (2009), 978-985.
42. E.I.Rigopoulou, D.P.Bogdanos, C. Liaskos, A.Koutsoumpas, H. Baum, D. Vergani and G.N. Dalekos, Antimitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblotdetected mitochondrial bands in patients with primary biliary cirrhosis, Clin Chim Acta 380 (2007), 118-121. (Pubitemid 46509627)
43. E.I. Rigopoulou, E.T. Davies, D.P. Bogdanos, C. Liaskos, M. Mytilinaiou, G.K. Koukoulis, G.N. Dalekos and D. Vergani, Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis, Liver Int 27 (2007), 1226-1231. (Pubitemid 47543151)
44. H.C. Mitchison, M.F. Bassendine, A. Hendrick, M.K. Bennett, G. Bird, A.J. Watson and O.F. James, Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?, Hepatology 6 (1986) 1279-1284. (Pubitemid 17210555)
45. J.V. Metcalf, H.C. Mitchison, J.M. Palmer, D.E. Jones, M.F. Bassendine and O.F. James, Natural history of early primary biliary cirrhosis, Lancet 348 (1996), 1399-1402. (Pubitemid 26395233)
46. M.E. Gershwin and I.R. Mackay, Primary biliary cirrhosis: paradigm or paradox for autoimmunity, Gastroenterology 100 (1991), 822-833.
47. J. Van de Water, M.E. Gershwin, P. Leung, A. Ansari and R.L. Coppel, The autoepitope of the 74kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase, J Exp Med 167 (1988), 1791-1799.
48. S.J.Yeaman, J.A.Kirby andD.E. Jones, Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis, Immunol Rev 174 (2000), 238-249. (Pubitemid 30201392)
49. S. Shimoda, M. Nakamura, H. Ishibashi, K. Hayashida and Y. Niho, HLA DRB4 0101restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases,J Exp Med 181 (1995), 1835-1845.
50. H. Kita, Z.X. Lian, J. Van de Water, X.S. He, S. Matsumura, M. Kaplan, V. Luketic, R.L. Coppel, A.A. Ansari and M.E. Gershwin, Identification of HLAA2restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes crosspresented by dendritic cells, J Exp Med 195 (2002), 113-123. (Pubitemid 34074501)
51. P.S. Leung, R.L.Coppel, A.Ansari, S.Munoz andM.E.Gershwin, Antimitochondrial antibodies in primary biliary cirrhosis, Semin Liver Dis 17 (1997), 61-69. (Pubitemid 27157372)
52. H. Baum, Nature of the mitochondrial antigens of primary biliary cirrhosis and their possible relationships to the etiology of the disease, Semin Liver Dis 9 (1989), 117-123. (Pubitemid 19126492)
53. H. Baum, Mitochondrial antigens, molecular mimicry and autoimmune disease, BiochimBiophys Acta 1271 (1995), 111-121.
54. H. Baum and P.A. Berg, The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis, Semin Liver Dis 1 (1981), 309-321.
55. L.Dubel, A. Tanaka, P.S. Leung, J.Van deWater, R. Coppel, T. Roche, C. Johanet, Y. Motokawa, A. Ansari and M.E. Gershwin, Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenasebinding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis, Hepatology 29 (1999), 1013-1018. (Pubitemid 29168730)
56. J.M. Palmer, D.E. Jones, J. Quinn, A. McHugh and S.J. Yeaman, Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis, Hepatology 30 (1999), 21-26. (Pubitemid 29300564)
57. P.S. Leung, T. Iwayama, R.L. Coppel and M.E. Gershwin, Sitedirected mutagenesis of lysine within the immunodominant autoepitope of PDCE2, Hepatology 12 (1990), 1321-1328.
58. J. Quinn, A.G. Diamond, J.M. Palmer, M.F. Bassendine, O.F. James and S.J. Yeaman, Lipoylated and unlipoylated domains of human PDCE2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment, Hepatology 18 (1993), 1384-1391. (Pubitemid 23348426)
59. S.M. Krams, C.D. Surh, R.L. Coppel, A. Ansari, B. Ruebner and M.E. Gershwin, Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis, Hepatology 9 (1989), 411-416. (Pubitemid 19074973)
60. M.D. Van Norstrand, M. Malinchoc, K.D. Lindor, T.M. Therneau, M.E. Gershwin, P.S. Leung, E.R. Dickson and H.A. Homburger, Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression, Hepatology 25 (1997), 6-11. (Pubitemid 27014977)
61. J. Neuberger, B. Portmann, B.R. Macdougall, R.Y. Calne and R.Williams, Recurrence of primary biliary cirrhosis after liver transplantation, N Engl J Med 306 (1982), 1-4. (Pubitemid 12194228)
62. J. Van de Water, D. Fregeau, P. Davis, A. Ansari, D. Danner, P. Leung, R. Coppel and M.E. Gershwin, Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function, J Immunol 141 (1988), 2321-2324.
63. S. Shimoda, J. Van de Water, A. Ansari, M. Nakamura, H. Ishibashi, R.L. Coppel, J. Lake, E.B. Keeffe, T.E. Roche and M.E. Gershwin, Identification and precursor frequency analysis of a common T cell epitopemotif inmitochondrial autoantigens in primary biliary cirrhosis, J Clin Invest 102 (1998), 1831-1840. (Pubitemid 28533830)
64. A. Lleo, C. Selmi, P. Invernizzi, M. Podda, R.L. Coppel, I.R. Mackay, G.J. Gores, A.A. Ansari, J. Van de Water and M.E. Gershwin, Apotopes and the biliary specificity of primary biliary cirrhosis, Hepatology 49 (2009), 871-879.
65. A. Lleo, C.L. Bowlus, G.X. Yang, P. Invernizzi, M. Podda, J. Van de Water, A.A. Ansari, R.L. Coppel, H.J. Worman, G.J. Gores and M.E. Gershwin, Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis, Hepatology. Jun 1. [Epub ahead of print].
66. S. Hannam, D.P. Bogdanos, E.T. Davies, M.J. Hussain, B.C. Portmann, G. MieliVergani and D. Vergani, Neonatal liver disease associated with placental transfer of antimitochondrial antibodies, Autoimmunity 35 (2002), 545-550. (Pubitemid 36321896)
67. M.E. Gershwin, C. Selmi, H.J. Worman, E.B. Gold, M. Watnik, J. Utts, K.D. Lindor, M.M. Kaplan and J.M. Vierling, Risk factors and comorbidities in primary biliary cirrhosis: a controlled interviewbased study of 1032 patients, Hepatology 42 (2005), 1194-1202. (Pubitemid 43112687)
68. A. ParikhPatel, E.B. Gold, H.Worman, K.E. Krivy and M.E. Gershwin, Risk factors for primary biliary cirrhosis in a cohort of patients from the united states, Hepatology 33 (2001), 16-21. (Pubitemid 32016882)
69. A. Floreani, M.F. Bassendine, H. Mitchison, R. Freeman and O.F. James, No specific association between primary biliary cirrhosis and bacteriuria? J Hepatol 8 (1989), 201-207. (Pubitemid 19074357)
70. M.I. Prince, S.J. Ducker and O.F. James, Casecontrol studies of risk factors for primary biliary cirrhosis in two United Kingdom populations, Gut 59, 508-512.
71. U. Hopf, B. Moller, R. Stemerowicz, H. Lobeck, A. Rodloff, M. Freudenberg, C. Galanos and D. Huhn, Relation between Escherichia coli R(rough)forms in gut, lipid A in liver, and primary biliary cirrhosis, Lancet 2 (1989), 1419-1422. (Pubitemid 20012059)
72. P. Butler, F. Valle, J.M. HamiltonMiller, W. Brumfitt, H. Baum and A.K. Burroughs, M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria, J Hepatol 17 (1993), 408-414. (Pubitemid 23134941)
73. J.J. Palermo, Recurrent urinary tract infection in mice results in immunemediated cholangiopathy similar to human primary biliary cirrhosis, Gastroenterology 134 (2008) A837 (abstract).
74. M.B. Oldstone, Molecular mimicry and autoimmune disease, Cell 50 (1987), 819-820.
75. D. Vergani, K. Choudhuri, D.P. Bogdanos and G. MieliVergani, Pathogenesis of autoimmune hepatitis, Clin Liver Dis 6 (2002), 727-737.
76. D.P. Bogdanos, G. MieliVergani and D. Vergani, Virus, liver and autoimmunity, Dig Liver Dis 32 (2000), 440-446.
77. D.P. Bogdanos and I.G. McFarlane, Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity, J Hepatol 39 (2003), 860-863. (Pubitemid 37372199)
78. D.P. Bogdanos, L. Muratori, F.B. Bianchi and D. Vergani, Hepatitis C virus and autoimmunity, Hepatology 31 (2000), 1380.
79. D.P. Bogdanos and E.I. Rigopoulou, Selfmimicking autoimmune domains of hepatitis C virus core antigen, Vaccine 24 (2006), 6173-6174. (Pubitemid 44262414)
80. D.P. Bogdanos and E.I. Rigopoulou, Viral/selfmimicry and immunological crossreactivity as a trigger of hepatic C virus associated autoimmune diabetes, Diabetes Res Clin Pract 77 (2007), 155-156. (Pubitemid 46613915)
81. D.P. Bogdanos, H. Smith, Y. Ma, H. Baum, G. MieliVergani and D. Vergani, A study of molecular mimicry and immunological crossreactivity between hepatitis B surface antigen and myelin mimics, Clin Dev Immunol 12 (2005), 217-224. (Pubitemid 43205646)
82. G.V. Gregorio, K. Choudhuri, Y. Ma, P. Pensati, R. Iorio, P. Grant, J. Garson, D.P. Bogdanos, A. Vegnente, G. MieliVergani and D. Vergani, Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection, Clin Exp Immunol 133 (2003), 404-413. (Pubitemid 37046966)
83. N. Kerkar, K. Choudhuri, Y. Ma, A. Mahmoud, D.P. Bogdanos, L.Muratori, F. Bianchi, R.Williams, G. MieliVergani and D. Vergani, Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self crossreactivity in liver kidney microsomal autoantibody type 1positive liver disease, J Immunol 170 (2003), 1481-1489. (Pubitemid 36139518)
84. L.Muratori, D.P. Bogdanos, P.Muratori,M. Lenzi, A.Granito, Y.Ma, G.MieliVergani, F.B. Bianchi and D.Vergani, Susceptibility to thyroid disorders in hepatitis C, Clin Gastroenterol Hepatol 3 (2005), 595-603. (Pubitemid 40824753)
85. D. Polymeros, D.P. Bogdanos, R. Day, D. Arioli, D. Vergani and A. Forbes, Does crossreactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn-s disease?, Gastroenterology 131 (2006), 85-96. (Pubitemid 44015754)
86. L. Wen, Y. Ma, D.P. Bogdanos, F.S. Wong, A. Demaine, G. MieliVergani and D. Vergani, Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity, Curr Mol Med 1 (2001), 379-389. (Pubitemid 33772964)
87. Y. Ma, M.G. Thomas, M. Okamoto, D.P. Bogdanos, S. Nagl, N. Kerkar, A.R. Lopes, L. Muratori, M. Lenzi, F.B. Bianchi, G. MieliVergani and D. Vergani, Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule, J Immunol 169 (2002), 277-285. (Pubitemid 34686146)
88. S.P. Fussey, J.G. Lindsay, C. Fuller, R.N. Perham, S. Dale, O.F. James, M.F. Bassendine and S.J. Yeaman, Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2oxo acid dehydrogenase complexes, Hepatology 13 (1991), 467-474.
89. H. Tanimoto, S. Shimoda, M. Nakamura, H. Ishibashi, A. Kawano, T. Kamihira, S. Matsushita, M.E. Gershwin and M. Harada, Promiscuous T cells selected by Escherichia coli: OGDCE2 in primary biliary cirrhosis, J Autoimmun 20 (2003), 255-263. (Pubitemid 36561491)
90. H. Baum, D.P. Bogdanos and D. Vergani, Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking Tcell epitope, J Hepatol 34 (2001), 785-787. (Pubitemid 32488803)